Furthermore, and similar to our previous observations in the LPS-sepsis model, intraperitoneal tumors from AP20187-treated presented a significant accumulation of infiltrating CD8 lymphocytes, highlighting the increased immune response to the tumor (Figure 5D). Here, CD8A is linked to neoplasm.